Background New treatments in coeliac disease are being vigorously pursued to either replace or facilitate the difficult-tofollow gluten-free diet.
Introduction
Last Prague consensus on coeliac disease (CD) focused on inadequate communication of the paediatrician or the paediatric gastroenterology with the adult gastroenterologist during the transition of the CD-affected adolescent to adulthood [1] . While diet adjustment may appear to be a straightforward intervention, adhering to a gluten-free diet is challenging nonetheless. This process is characterised by mental, physical, cultural and psychological aspects and was dealt as a priority by the American Academy of Pediatrics in 2011 [2] . However, specifically, the recommendations for the transition in CD are rare and not topic oriented [3] . This is the reason why the Prague consensus report team should be congratulated for undertaking the task [1] . This review focuses on the gluten-free diet (GFD) difficulties during the transition. To set up the stage, several aspects of the GFD in CD will be expanded and updated.
The magnitude of dropout rates or nonadherence to GFD in CD Based upon patient's self-report and the physician experience, the intake of gluten during GFD is fairly common. In fact, up to 50% of patients with CD report consuming gluten, either intentionally or unintentionally, while on GFD [4, 5] resulting in persistent mucosal damage [5] . Approximately half of the patients with CD reported dietary compliance, the European rate of compliance range being 44-97% [1, 6] . More so, unrecognized gluten consumption is the most commonly identified cause of nonresponsive coeliac disease [7] .
Why adherence to GFD is problematic in the transition period Table 1 summarises the main difficulties in GFD consumption resulting in low or nonadherence to gluten withdrawal. It should be stated that the ratio of occurrence between children and adolescents is 1 : 104. When CD is diagnosed during adolescence, normal developmental tasks become more challenging, therefore impacting gluten withdrawal adherence [11] . a These authors contributed equally to this work.
The transition period brings some more resons for poor compliance, due to the adolescence period, the young adults and the transition itself.
CD diagnosis and management can negatively affect the adolescent, impacting his/her physical and mental development, responsibilities, balanced social and behavioural life, school attendance, health management, identity confusion, risk taking, authority acceptance and nutritional restrictions are imposed on potentially inadequate emotional, corporal and cognitive capabilities of the adolescent [3] . Limited life experience, sense of adolescent invincibility, reluctance to abandon their paediatric lifestyle resulting in a sense of fear or anxiety are some of the adolescence period difficulties while facing transition.
The young adult when entering a totally different adult medical follow-up set-up is faced with some additional stressful difficulties: insufficient knowledge on CD, on GFD, and on one's personal, emotional, medical and family history, lack of chemistry and friendly cross-talks, too buzzy outpatients' clinic and facing adult and elderly populations with chronic disease.
The transition itself is a vulnerable, fragile and potentially multirisk process, and its successful and smooth outcome might impact the patients' health and their GFD compliance.
How to monitor GFD adherence
The biomarkers to monitor GFD compliance in CD were very recently summarised [12] . Table 2 lists most of those markers. It seems that the serological tests are the most frequently used ones, but we are far away from a good and reliable marker to monitor GFD adherence.
Highlights in the transition process from childhood to adulthood with CD, as reflected in the Prague consensus
Failure to respond to a GFD was an important problem in the transition process of childhood to adulthood in CD-affected patients [15] . Most children with CD received no medical or dietary supervision after transition to an adult clinic follow-up, and one-third appeared to be not complying with GFD [6] . However, over one-quarter of departments reported that their dietitians were allocated up to 100 000 patients with CD with the cycle of 1 h per month to monitor them [16] . However, for many patients, the GFD was a matter of personal choice rather than a professional, originated prescription [17] . Interventions were designed to reduce the perceived burden of the GFD [18] . Management encompassed supporting patients with adherence to the GFD and establishment of CD-focused clinical review every 1-2 years [19] . Patients' continuous support was a part of CD management [20] . Adherence to a GFD required dietary advice from a certified clinical dietitian [21] . In fact, children with CD excluded, under dietitian observation, all the products containing wheat, barley and rye from their diet [22] . Ethnicity and education levels played an important role in gluten-free product perception [23] . Composition of database of gluten-free products was necessary and effective [24] . Nurses, being an integral part of the team, were also involved in initiating GFD to CD children [25] . But dietetic consultations and follow-up were more important for the patients [26] , because the ideal amount of gluten introduced at weaning was a major issue in the newborns [27] . Notably, the amount of gluten consumed before 2 years of age increased the risk of CD at least two-fold in genetically susceptible children [28] . Many patients with CD felt better on a GFD [29] but many other patients with CD pronounced themselves in favour of the alternative drugs development [8, 30] . Experimental therapies for CD were discussed [8, 31] . For example, a new potential form of nondietary pharmaceutical therapy for CD, such as larazotide acetate, was discussed in the consensus. This pharmaceutical agent is capable of inhibiting the actin rearrangement caused by gliadin [32] and is currently being evaluated in clinical trials. The GF database was a helpful tool for patients with CD to find the food composition of their GFD [33] , because many people under GFD had difficulties to correctly find foods that are GF [34] . In addition, the Food and Drug Administration developed protocols for clinical assessment in therapeutic trail such as The Celiac Disease Symptom Diary (CDSD) and Celiac Disease Patient Reported Outcome (CeD-PRO) [35] . Finally, as the stage is set for the above-mentioned background, following are the Prague consensus recommendations to improve GFD adherence.
The Prague consensus recommendations on GFD adherence during the transitional period
The Prague consensus recommended that dietary adherence and the consequences of nonadherence should be discussed during transition. As GFD is the only accepted treatment for CD [36] , the role of a therapeutic and follow-up team, having the professional skills in gluten-related disorders, is crucial to find inadvertent gluten intake [37] . In fact, practically speaking, the adherence to the GFD can meet the therapeutic goals in almost all patients with CD [38] . Dietary adherence improved health-related quality of life (HRQoL) of patients with CD [39] . Significant associations have been reported between HRQoL measures and adherence, but these findings were not always consistent [40] . Follow-up of adherence was difficult because there were no objective measurements to assess gluten withdrawal and compliance [41] . At the end of the day, the ways to measure and improve adherence to GFD are still controversial and far from being resolved [42] .
Conclusions
Transition of information related to adolescent adherence to GFD to an adult gastroenterologist is multi-faced, complex and somehow labile and fragile, and represents a tough ally in torrid time. It demands a tight cooperation and mutual crosstalks between the paediatric team and the adult gastroenterologist, to coordinate a smooth, pleasant and effective transition. It is hoped that the Consensus report recommendations will be followed up and implemented. As GFD in CD is the 'chameleon among the food intolerances' and as transition from adolescence to adulthood embeds multiple problems and risks, the consensus recommendations represent a step forward to ameliorate the GFD adherence in adolescent-young adult patients with CD.
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